A complex interplay of prenatal and postnatal factors determines the risk of childhood obesity and diabetes during later life.
Whether saving for retirement or living a healthier lifestyle, a new report from the Parliamentary Office of Science and Technology hopes to inform...
Epigenetics is taking the biomedical research world by storm; three Cambridge scientists use examples from their own research to explain why.
GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity...
University of Cambridge to pioneer drug development by academic incubators.
A new centre on the Cambridge Biomedical Campus next to Addenbrooke's Hospital will address the growing threat...
MRC-supported initiatives on the Cambridge Biomedical Campus aim to combat health problems linked with obesity and lifestyle.
Assessing the chance of something happening or not happening confronts us all the time. A new programme led by David Spiegelhalter, the Winton...
For some people, the urge to eat is uncontrollable. Cambridge scientists have taken us a step closer to understanding the causes of obesity by...
